What is the expected outcome for the client receiving filgrastim (Neupogen)?
1. Increased white cell count
2. Reduction in tumor size
3. Reduction in paresthesia
4. Increased platelet count
Correct Answer: 1
Rationale 1: Filgrastim increases white cell counts.
Rationale 2: Filgrastim has no effect on tumor size.
Rationale 3: Filgrastim does not reduce paresthesia.
Rationale 4: Filgrastim has no effect on platelet counts.
Global Rationale: Filgastim is a colony-stimulating factor which stimulates the production of granulocytes. It has no effect on tumor size, does not reduce paresthesia, and has no effect on platelet counts.
You might also like to view...
The length of time insulin works is referred to as the
A. onset. B. peak. C. duration. D. trough.
Which patient is most likely to be a candidate for total parenteral nutrition (TPN) rather than enteral nutrition?
a. A patient who is comatose after having had a stroke b. A patient who has a fractured mandible following a motor vehicle accident c. A patient who has cerebral palsy and severe dysphagia d. A patient who is pregnant and has intractable hyperemesis gravidarum
The client has been started on Artane. The nurse notes that the client's bowel sounds are decreasing. What is the highest priority action on the part of the nurse?
a. Administer the drug; this is an expected reaction. b. Administer the drug; this is an expected side effect. c. Hold the drug; this is an adverse reaction to the drug. d. Hold the drug; this is a life-threatening response.
Convert 0.203 L to milliliters: ________ (use appropriate unit abbreviation)
Fill in the blank(s) with the appropriate word(s).